• Journal Article

Cardiovascular and cerebrovascular events among patients receiving omalizumab: Pooled analysis of patient-level data from 25 randomized, double-blind, placebo-controlled clinical trials

Citation

Iribarren, C., Rothman, K. J., Bradley, M. S., Carrigan, G., Eisner, M. D., & Chen, H. (2017). Cardiovascular and cerebrovascular events among patients receiving omalizumab: Pooled analysis of patient-level data from 25 randomized, double-blind, placebo-controlled clinical trials. Journal of Allergy and Clinical Immunology. DOI: 10.1016/j.jaci.2016.12.953

Abstract